Haemolysis associated with the treatment of malaria with artemisinin derivatives: A systematic review of current evidence

International Journal of Infectious Diseases

Volumn 29, Issue , 2014, Pages e268-e273

  Rehman, Khalid ^a   Lötsch, Felix ^a,b   Kremsner, Peter G ^b,c   Ramharter, Michael ^a,b,c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Centre de Recherches Médicales de Lambaréné HÔpital Albert Schweitzer   (Gabon)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Anaemia; Artemisinin; Artesunate; Falciparum; Haemolysis; Malaria

Indexed keywords

ARTEMETHER; ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ DERIVATIVE; ARTESUNATE; ATOVAQUONE PLUS PROGUANIL; HEMOGLOBIN; MEFLOQUINE; ANTIMALARIAL AGENT;

ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG SAFETY; DRUG USE; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HEMOLYSIS; HUMAN; MALARIA; SYSTEMATIC REVIEW; THERAPY DELAY; TRAVEL; ADULT; AGED; CHILD; DRUG EFFECTS; FEMALE; INFANT; MALE; MIDDLE AGED;

ADULT; AGED; ANTIMALARIALS; ARTEMISININS; CHILD; FEMALE; HEMOLYSIS; HUMANS; INFANT; MALARIA; MALE; MIDDLE AGED;

EID: 84911995061     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2014.09.007     Document Type: Article

References (33)

1. World Health Organization Malaria report 2013, WHO, Geneva.
2. Auer-Hackenberg L., Staudinger T., Bojic A., Locker G., Leitner G.C., Graninger W., et al. Automated red blood cell exchange as an adjunctive treatment for severe Plasmodium falciparum malaria at the Vienna General Hospital in Austria: a retrospective cohort study. Malaria J 2012, 11:158.
3. Ramharter M., Wernsdorfer W.H., Kremsner P.G. In vitro activity of quinolines against Plasmodium falciparum in Gabon. Acta Trop 2004, 90:55-60.
4. Sinclair D., Zani B., Donegan S., Olliaro P., Garner P. Artemisinin-based combination therapy for treating uncomplicated malaria. Cochrane Database Syst Rev 2009, (3):CD007483.
5. Verdrager J. Averting a malaria disaster. Lancet 1999, 354:1389-1390.
6. Askling H.H., Bruneel F., Burchard G., Castelli F., Chiodini P.L., Grobusch M.P., et al. Management of imported malaria in Europe. Malar J 2012, 11:328.
7. Kremsner P.G., Krishna S. Antimalarial combinations. Lancet 2004, 364:285-294.
8. World Health Organization Malaria treatment guidelines 2006, WHO, Geneva.
9. Dondorp A., Nosten F., Stepniewska K., Day N., White N. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet 2005, 366:717-725. South East Asian Quinine Artesunate Malaria Trial, group.
10. Dondorp A.M., Fanello C.I., Hendriksen I.C.E., Gomes E., Seni A., Chhaganlal K.D., et al. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet 2010, 376:1647-1657.
11. World Health Organization Malaria treatment guidelines 2010, WHO, Geneva.
12. Rolling T., Schmiedel S., Wichmann D., Wittkopf D., Burchard G.D., Cramer J.P. Post-treatment haemolysis in severe imported malaria after intravenous artesunate: case report of three patients with hyperparasitaemia. Malaria J 2012, 11:169.
13. Rolling T., Wichmann D., Schmiedel S., Burchard G.D., Kluge S., Cramer J.P. Artesunate versus quinine in the treatment of severe imported malaria: comparative analysis of adverse events focussing on delayed haemolysis. Malar J 2013, 12:241.
14. Eder M., Farne H., Cargill T., Abbara A., Davidson R.N. Intravenous artesunate versus intravenous quinine in the treatment of severe falciparum malaria: a retrospective evaluation from a UK centre. Pathog Glob Health 2012, 106:181-187.
15. Kano S. Artemisinin-based combination therapies and their introduction in Japan. J Infect Chemother 2010, 16:375-382.
16. Caramello P., Balbiano R., De Blasi T., Chiriotto M., Deagostini M., Calleri G. Severe malaria, artesunate and haemolysis. J Antimicrob Chemother 2012, 67:2053-2054.
17. Zoller T., Junghanss T., Kapaun A., Gjorup I., Richter J., Hugo-Persson M., et al. Intravenous artesunate for severe malaria in travelers, Europe. Emerg Infect Dis 2011, 17:771-777.
18. Kreeftmeijer-Vegter A.R., van Genderen P.J., Visser L.G., Bierman W., Clerinx J., van Veldhuizen C., et al. Treatment outcome of intravenous artesunate in patients with severe malaria in the Netherlands and Belgium. Malar J 2012, 11:102.
19. Rolling T., Agbenyega T., Issifou S., Adegnika A.A., Sylverken J., Spahlinger D., et al. Delayed hemolysis after treatment with parenteral artesunate in African children with severe malaria-a double-center prospective study. J Infect Dis 2014, 209(Jun (12)):1921-1928.
20. World Health Organization Communicable Disease Cluster, Geneva, Switzerland. Severe falciparum malaria definition. Trans R Soc Trop Med Hyg 2000, 94(Apr (Suppl 1)):S1-S90.
21. Jarvis J.N., Coltart C.E., Pule M., Chiodini P.L., Doherty T. Artemisinin therapy and severe delayed haemolysis. Lancet 2013, 382:180.
22. Rouya L., Leonard P., Hayette M. A case of hemolytic anemia after severe malaria successfully treated with artesunate. Joined Symposium belgische vereniging voor infectiologie en klinische microbiologie. Scientific Study Group for Travel Medicine 2013.
23. De Nardo P., Oliva A., Giancola M.L., Ghirga P., Mencarini P., Bibas M., et al. Haemolytic anaemia after oral artemether-lumefantrine treatment in a patient affected by severe imported falciparum malaria. Infection 2013, 41:863-865.
24. Corpolongo A., De Nardo P., Ghirga P., Gentilotti E., Bellagamba R., Tommasi C., et al. Haemolytic anaemia in an HIV-infected patient with severe falciparum malaria after treatment with oral artemether-lumefantrine. Malar J 2012, 11:91.
25. Centers for Disease Control and Prevention Published reports of delayed HA after treatment with artesunate for severe malaria 2013, CDC, Atlanta, USA.
26. Medicines for Malaria Venture Injectable Artesunate Expert Group Meeting in Vienna 2013, MMV, Geneva, Switzerland.
27. Kremsner P.G., Taylor T., Issifou S., Kombila M., Chimalizeni Y., Kawaza K., et al. A simplified intravenous artesunate regimen for severe malaria. J Infect Dis 2012, 205:312-319.
28. Cramer J.P., Lopez-Velez R., Burchard G.D., Grobusch M.P., de Vries P.J. Treatment of imported severe malaria with artesunate instead of quinine-more evidence needed?. Malar J 2011, 10:256.
29. Chotivanich K., Udomsangpetch R., McGready R., Proux S., Newton P., Pukrittayakamee S., et al. Central role of the spleen in malaria parasite clearance. J Infect Dis 2002, 185:1538-1541.
30. Angus B.J., Chotivanich K., Udomsangpetch R., White N.J. In vivo removal of malaria parasites from red blood cells without their destruction in acute falciparum malaria. Blood 1997, 90:2037-2040.
31. Del Portillo H.A., Ferrer M., Brugat T., Martin-Jaular L., Langhorne J., Lacerda M.V. The role of the spleen in malaria. Cell Microbiol 2012, 14:343-355.
32. Ramharter M., Kurth F., Schreier A.C., Nemeth J., von Glasenapp I., Bélard S., et al. Fixed-dose pyronaridine-artesunate combination for treatment of uncomplicated falciparum malaria in pediatric patients in Gabon. J Infect Dis 2008, 198:911-919.
33. Ramharter M., Kurth F.M., Bélard S., Bouyou-Akotet M.K., Mamfoumbi M.M., Agnandji S.T., et al. Pharmacokinetics of two paediatric artesunate-mefloquine drug formulations in the treatment of uncomplicated falciparum malaria in Gabon. J Antimicrob Chemother 2007, 60:1091-1096.